Characteristics of Australian and New Zealand patients with chronic lymphocytic leukaemia: a lymphoma and related diseases registry report

Documenti analoghi

• Australians with chronic lymphocytic leukaemia continue to have high rates of second primary malignancies in the modern era
  di: Diva Baggio, et al.
  Pubblicazione: (2024)
• Australia and New Zealand consensus statement on the cardiovascular management of patients with chronic lymphocytic leukaemia treated with Bruton's tyrosine kinase inhibitors
  di: Mary Ann Anderson, et al.
  Pubblicazione: (2025)
• Learnings from phosphatidylinositol 3‐kinase inhibitors in lymphoma—Moving to a model where less can be more
  di: Arina Martynchyk, et al.
  Pubblicazione: (2024)
• Outcomes of allogeneic haemopoietic transplant for chronic lymphocytic leukaemia in the modern era
  di: Luani Barge, et al.
  Pubblicazione: (2025)
• Economic burden of sickle cell disease in Australia
  di: Steve Nwokeocha, et al.
  Pubblicazione: (2025)